Needle-Free Adrenaline: Where EURneffy® Fits
- Allergy Aware UK
- Aug 26
- 1 min read
The MHRA has approved EURneffy®, a nasal spray adrenaline for emergency treatment of anaphylaxis in people ≥30 kg. Auto-injectors are still essential.
Who this helps: Anyone prescribed adrenaline for anaphylaxis, plus families, schools, and workplaces.
Key takeaways
Needle-free option may help those with needle fear.
Know your device: technique differs from auto-injectors.
Still advised to carry two doses at all times.
What’s new
In July 2025, MHRA approved the first needle-free adrenaline spray for the UK. It delivers adrenaline quickly without a needle.
What hasn’t changed
Act fast: use at the first sign of anaphylaxis.
Give a second dose after 5 minutes if needed.
Always call 999 and follow your action plan.
Practical steps
Ask your doctor if EURneffy is right for you.
Ensure friends/family know which device you carry.
Practise technique — whether spray or pen.
When to seek help:Always. Anaphylaxis is life-threatening. Use adrenaline immediately and call 999.
References
MHRA (2025) MHRA approves adrenaline nasal spray. Available at: https://www.gov.uk/government/news/mhra-approves-adrenaline-nasal-spray-the-first-needle-free-emergency-treatment-for-anaphylaxis-in-the-uk
Comments